Author + information
- Robert L. McNamara,
- Sheng-Chia Chung,
- Tomas Jernberg,
- DaJuanicia Holmes,
- Matthew Roe,
- Adam Timmis,
- Stefan James,
- John Deanfield,
- Gregg Fonarow,
- Eric Peterson,
- Anders Jeppsson and
- Harry Hemingway
Comparisons among countries in the management of consecutive patients with acute non ST segment elevation myocardial infarction (NSTEMI) are lacking.
We compared the use of in-hospital procedures and discharge medications for patients with NSTEMI from 2007 to 2010 using the MINAP/NICOR (UK; n=137,009), SWEDEHEART/RIKS-HIA (Sweden; n=45,069), and ACTION Registry-GWTG (US; n=148,194) clinical registries.
The US registry had a higher proportion of PCI-capable hospitals. Patients in the UK and Sweden registries were older but less likely to have comorbid conditions. Angiography and PCI were performed less often and beta-blockers at discharge were prescribed less often in the UK compared with Sweden and the US. However, prescription of dual antiplatelet agents, statins, and ACEI/ARB were highest in the UK. Over the four years, the performance of PCI increased most in the UK but remained lower than in the other two countries. Dual antiplatelet and ACEI/ARB use increased in Sweden, and beta-blocker use increased in the UK. Use of other medication was relatively stable. (Table)
Differences exist in the acute management of patients after NSTEMI among hospitals in these registries in the UK, Sweden, and the US. Gaps in care are narrowing in some practices but not in others. Understanding these differences may identify areas for improvement as well as provide insight for future investigations into outcomes.
Poster Sessions, Expo North
Monday, March 11, 2013, 9:45 a.m.-10:30 a.m.
Session Title: PCI: Outcomes, Adherence and Appropriateness
Abstract Category: 28. Quality of Care and Outcomes Assessment
Presentation Number: 1288-104
- 2013 American College of Cardiology Foundation